Journal
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
Volume 133, Issue -, Pages 184-189Publisher
ELSEVIER
DOI: 10.1016/j.ijbiomac.2019.04.099
Keywords
Human carboxylesterase 2; Triterpenoid; Docking
Funding
- National Natural Science Foundation of China [81703679]
- National Key Research and Development Program of China [2018YFC1705900]
Ask authors/readers for more resources
As a part of our searching for natural human carboxylesterase 2 (human CES 2) inhibitors from traditional Chinese medicine, we found that the extract of Alisma orientale significantly inhibited human CES 2 in vitro. The investigation on A. orientale led to the isolation of a new protostane-type triterpenoid alismanin I (1). Its structure was determined according to HRESIMS, 1D and 2D NMR spectra. Alismanin 1(1) displayed significantly inhibitory activity against human CES 2 with IC50 value of 131 0.09 pM assayed by human CES 2-mediated DDAB hydrolysis. According to its inhibition kinetic result, compound I was a noncompetitive type inhibitor, and its Ki was 3.65 pM. Its inhibitory effect was confirmed in living cell level through a visual manner. The potential interaction mechanism of compound 1 with human CES 2 was also analyzed by circular dichroism (CD) spectrum and molecular docking. (C) 2019 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available